Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Change in Account Payables (2021 - 2025)

Biote (BTMD) has 5 years of Change in Account Payables data on record, last reported at $496000.0 in Q3 2025.

  • For Q3 2025, Change in Account Payables rose 137.18% year-over-year to $496000.0; the TTM value through Sep 2025 reached -$65000.0, up 95.91%, while the annual FY2024 figure was $1.5 million, 1036.36% up from the prior year.
  • Change in Account Payables reached $496000.0 in Q3 2025 per BTMD's latest filing, down from $528000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.4 million in Q2 2023 and bottomed at -$4.1 million in Q4 2022.
  • Average Change in Account Payables over 5 years is $102473.7, with a median of $528000.0 recorded in 2025.
  • Peak YoY movement for Change in Account Payables: soared 373603.04% in 2022, then crashed 2173.39% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at -$321000.0 in 2021, then tumbled by 1164.8% to -$4.1 million in 2022, then surged by 56.97% to -$1.7 million in 2023, then surged by 179.51% to $1.4 million in 2024, then crashed by 64.29% to $496000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were $496000.0 in Q3 2025, $528000.0 in Q2 2025, and -$2.5 million in Q1 2025.